RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer

Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer

4th Jan 2006, 23:52 GMT

A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy. This is a companion study to a paper released today in the New England Journal of Medicine showing longer survival for women who received IP chemotherapy compared with those who received the standard intravenous (IV) regimen.

View full story at www.eurekalert.org

Intraperitoneal chemotherapy administration prolongs survival for women with advanced ovarian cancer related news:

Latest news from EurekAlert! - Breaking News: